Design and validation of a clinical-scale bioreactor for long-term isolated lung culture


The primary treatment for end-stage lung disease is lung transplantation. However, donor organ shortage remains a major barrier for many patients. In recent years, techniques for maintaining lungs ex vivo for evaluation and short-term (<12 h) resuscitation have come into more widespread use in an attempt to expand the donor pool. In parallel, progress in… (More)
DOI: 10.1016/j.biomaterials.2015.02.016


6 Figures and Tables